| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return |
|---|---|---|---|---|---|
|
SRPT
Sarepta Therapeutics
|
Jun 18, 2026 | HOLD |
Buy
+251.8% avg upside
49 analysts
|
$19.00
12.13% Upside
|
· |
|
GILD
Gilead Sciences
|
Jun 08, 2026 | HOLD |
Strong Buy
-5.6% avg upside
66 analysts
|
$122.00
2.84% Downside
|
-2.8% |
|
APGE
Apogee Therapeutics
|
Jun 08, 2026 | HOLD |
Strong Buy
+31.2% avg upside
19 analysts
|
$97.00
9.66% Upside
|
+6.5% |
|
VRTX
Vertex Pharmaceuticals
|
Jun 04, 2026 | BUY |
Strong Buy
-3.9% avg upside
61 analysts
|
$543.00
18.31% Upside
|
+3.9% |
|
NBIX
Neurocrine
|
May 29, 2026 | BUY |
Strong Buy
+8.0% avg upside
37 analysts
|
$183.00
15.00% Upside
|
+0.9% |
|
BIIB
Biogen
|
May 27, 2026 | BUY |
Strong Buy
+24.4% avg upside
51 analysts
|
$227.00
14.27% Upside
|
+0.9% |
|
CRBP
Corbus Pharmaceuticals
|
May 26, 2026 | BUY |
Strong Buy
+346.7% avg upside
20 analysts
|
$36.00
347.25% Upside
|
· |
|
REGN
Regeneron
|
May 17, 2026 | HOLD |
Strong Buy
+27.5% avg upside
57 analysts
|
$707.00
16.23% Upside
|
-2.2% |
|
ATYR
aTyr Pharma
|
May 15, 2026 | HOLD |
Buy
+1967.4% avg upside
17 analysts
|
$1.00
115.98% Upside
|
· |
|
KPTI
Karyopharm Therapeutics
|
May 14, 2026 | BUY |
Strong Buy
+139.5% avg upside
18 analysts
|
$16.00
70.23% Upside
|
-13.8% |
|
GHRS
GH Research
|
May 14, 2026 | BUY |
Strong Buy
+67.1% avg upside
11 analysts
|
$40.00
84.33% Upside
|
-4.9% |
|
LKFT
Lakefront Biotherapeutics
|
May 13, 2026 | HOLD |
Hold
+272.1% avg upside
24 analysts
|
$28.00
1.27% Downside
|
· |
|
DMRA
Damora Therapeutics
|
May 12, 2026 | BUY |
Strong Buy
+26.5% avg upside
19 analysts
|
$40.00
86.66% Upside
|
· |
|
SION
Sionna Therapeutics, Inc.
|
May 12, 2026 | SELL |
Strong Buy
+46.5% avg upside
11 analysts
|
$23.00
37.48% Downside
|
+15.1% |
|
EVMN
Evommune, Inc.
|
May 12, 2026 | BUY |
Strong Buy
+144.9% avg upside
12 analysts
|
$50.00
142.07% Upside
|
-11.6% |
|
PLRX
Pliant Therapeutics
|
May 11, 2026 | HOLD |
Buy
+1806.3% avg upside
21 analysts
|
$2.00
69.52% Upside
|
+2.5% |
|
MLTX
MoonLake Immunotherapeutics
|
May 11, 2026 | HOLD |
Strong Buy
+51.0% avg upside
20 analysts
|
$16.00
16.68% Downside
|
+1.9% |
|
PRTA
Prothena
|
May 08, 2026 | HOLD |
Buy
+171.8% avg upside
14 analysts
|
$13.00
53.11% Upside
|
-20.9% |
|
NMRA
Neumora Therapeutics, Inc.
|
May 07, 2026 | BUY |
Strong Buy
+427.6% avg upside
11 analysts
|
$7.00
357.52% Upside
|
-5.1% |
|
PTCT
PTC Therapeutics
|
May 07, 2026 | HOLD |
Strong Buy
-1.0% avg upside
29 analysts
|
$82.00
4.38% Upside
|
+21.8% |
|
XENE
Xenon
|
May 07, 2026 | BUY |
Strong Buy
+18.6% avg upside
28 analysts
|
$82.00
54.14% Upside
|
-6.4% |
|
DFTX
Definium Therapeutics
|
May 07, 2026 | BUY |
Strong Buy
+46.3% avg upside
20 analysts
|
$36.00
47.32% Upside
|
+5.3% |
|
AARD
Aardvark Therapeutics, Inc.
|
May 07, 2026 | HOLD |
Buy
+399.2% avg upside
12 analysts
|
$6.00
57.09% Upside
|
-14.8% |
|
ACAD
ACADIA Pharmaceuticals
|
May 06, 2026 | BUY |
Strong Buy
+66.6% avg upside
42 analysts
|
$29.00
34.17% Upside
|
+0.6% |
|
BCRX
BioCryst
|
May 06, 2026 | BUY |
Strong Buy
+102.2% avg upside
24 analysts
|
$13.00
45.34% Upside
|
-4.5% |
|
CTNM
Contineum Therapeutics, Inc. Class A
|
May 05, 2026 | BUY |
Strong Buy
+68.2% avg upside
8 analysts
|
$22.00
80.96% Upside
|
-11.0% |
|
KYMR
Kymera Therapeutics
|
Apr 30, 2026 | BUY |
Strong Buy
+9.5% avg upside
36 analysts
|
$106.00
17.85% Upside
|
+5.6% |
|
INCY
Incyte
|
Apr 28, 2026 | HOLD |
Buy
+1.0% avg upside
47 analysts
|
$95.00
4.05% Downside
|
+1.3% |
|
NRIX
Nurix Therapeutics
|
Apr 08, 2026 | BUY |
Strong Buy
+79.9% avg upside
26 analysts
|
$30.00
75.32% Upside
|
+12.7% |
|
TSE:SOBO
South Bow Corp
|
Oct 26, 2025 | BUY |
Hold
-10.3% avg upside
20 analysts
|
$39.00
23.33% Downside
|
· |
|
ENTA
Enanta Pharmaceuticals
|
Oct 02, 2023 | HOLD |
Buy
+160.1% avg upside
17 analysts
|
$15.00
18.69% Upside
|
+7.2% |
|
VERX
Vertex
|
Oct 28, 2022 | HOLD |
Buy
+218.1% avg upside
22 analysts
|
$288.00
2421.83% Upside
|
+27.8% |
|
ATAI
Atai Beckley N.V.
|
May 16, 2022 | HOLD |
Strong Buy
+230.0% avg upside
16 analysts
|
$8.00
96.62% Upside
|
-52.0% |
|
OVID
Ovid Therapeutics
|
Aug 16, 2021 | HOLD |
Strong Buy
+98.5% avg upside
17 analysts
|
$4.00
65.19% Upside
|
-41.2% |
|
AMGN
Amgen
|
Oct 26, 2017 | HOLD |
Buy
-12.2% avg upside
57 analysts
|
$188.00
45.05% Downside
|
+8.4% |
|
ABEO
Abeona Therapeutics
|
Sep 15, 2017 | BUY |
Strong Buy
+200.8% avg upside
17 analysts
|
$23.00
307.00% Upside
|
-16.6% |
|
CVX
Chevron
|
May 17, 2017 | BUY |
Strong Buy
+5.2% avg upside
43 analysts
|
$135.00
24.04% Downside
|
+28.4% |
|
RARE
Ultragenyx Pharmaceutical
|
May 08, 2017 | HOLD |
Strong Buy
+144.1% avg upside
36 analysts
|
$68.00
152.77% Upside
|
-3.8% |
|
OSK
Oshkosh
|
Apr 27, 2017 | BUY |
Strong Buy
+3.6% avg upside
26 analysts
|
$80.00
42.02% Downside
|
+3.1% |
|
ARCT
Arcturus Therapeutics
|
Mar 31, 2017 | HOLD |
Buy
+298.1% avg upside
35 analysts
|
$8.75
18.79% Upside
|
-31.1% |
|
PEG
Public Service Enterprise
|
Mar 31, 2017 | HOLD |
Buy
+7.3% avg upside
31 analysts
|
$46.50
41.49% Downside
|
+17.5% |
|
FE
FirstEnergy
|
Mar 31, 2017 | HOLD |
Buy
+4.8% avg upside
25 analysts
|
$32.00
30.62% Downside
|
+12.0% |
|
QURE
uniQure
|
Mar 07, 2017 | HOLD |
Strong Buy
+2.0% avg upside
29 analysts
|
$8.00
83.38% Downside
|
+345.4% |
|
AFMDQ
Affimed
|
Feb 16, 2017 | HOLD |
Buy
+12648900.0% avg upside
15 analysts
|
$2.50
2499900.02% Upside
|
· |
|
DBVT
DBV Technologies SA - American
|
Feb 09, 2017 | BUY |
Strong Buy
+49.4% avg upside
15 analysts
|
$47.00
188.61% Upside
|
-36.6% |
|
HAE
Haemonetics
|
Jan 05, 2017 | BUY |
Buy
-8.0% avg upside
17 analysts
|
$42.00
42.22% Downside
|
+59.1% |
|
CLDX
Celldex
|
Nov 23, 2016 | HOLD |
Strong Buy
+18.8% avg upside
28 analysts
|
$5.00
84.77% Downside
|
-34.0% |
|
RRC
Range Resources
|
Nov 16, 2016 | BUY |
Buy
+4.2% avg upside
43 analysts
|
$46.00
25.51% Upside
|
-49.8% |
|
CMCSA
Comcast
|
Nov 16, 2016 | BUY |
Buy
+73.5% avg upside
41 analysts
|
$38.50
69.62% Upside
|
+11.7% |
|
CVS
CVS Health
|
Nov 01, 2016 | BUY |
Strong Buy
+2.5% avg upside
38 analysts
|
$122.00
22.99% Upside
|
-15.2% |
|
BMRN
BioMarin Pharmaceutical
|
Sep 07, 2016 | BUY |
Strong Buy
+71.7% avg upside
52 analysts
|
$120.00
118.18% Upside
|
-5.9% |
|
ABBV
AbbVie
|
Aug 25, 2016 | BUY |
Buy
+1.3% avg upside
43 analysts
|
— | +16.3% |
|
TEVA
Teva Pharmaceutical
|
Aug 25, 2016 | BUY |
Buy
-8.1% avg upside
39 analysts
|
— | -67.2% |
|
BMY
Bristol-Myers Squibb
|
Aug 22, 2016 | HOLD |
Buy
+7.4% avg upside
42 analysts
|
— | +0.1% |
|
LLY
Eli Lilly & Co
|
Aug 08, 2016 | BUY |
Strong Buy
-11.2% avg upside
47 analysts
|
— | +3.1% |
|
AGEN
Agenus
|
Aug 08, 2016 | BUY |
Strong Buy
+167.7% avg upside
17 analysts
|
— | -37.3% |
|
JNJ
Johnson & Johnson
|
Aug 01, 2016 | HOLD |
Strong Buy
-5.2% avg upside
36 analysts
|
— | +8.5% |
|
CLLS
Cellectis SA
|
Jul 15, 2016 | BUY |
Strong Buy
+551.9% avg upside
16 analysts
|
— | +8.1% |
|
PFE
Pfizer
|
Jul 15, 2016 | BUY |
Buy
+31.7% avg upside
45 analysts
|
— | -5.6% |
|
MRK
Merck & Company
|
Jul 15, 2016 | HOLD |
Strong Buy
+9.8% avg upside
43 analysts
|
— | +8.9% |
|
NVS
Novartis
|
Apr 21, 2016 | BUY |
Hold
-9.3% avg upside
24 analysts
|
$60.50
60.00% Downside
|
-0.2% |
|
RIGL
Rigel
|
Feb 23, 2015 | HOLD |
Strong Buy
-28.0% avg upside
17 analysts
|
— | -28.2% |
|
PLX
Protalix
|
Jun 25, 2012 | HOLD |
Buy
+307.6% avg upside
4 analysts
|
— | -16.3% |
|
NVAX
Novavax
|
Sep 02, 2009 | HOLD |
Buy
+146.7% avg upside
20 analysts
|
— | -60.9% |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.